Proteome Systems, a biotech based in Sydney, Australia, is set to
receive the backing of a foundation funded by Bill Gates to conduct
research into a possible test for tuberculosis. The Foundation for
Innovative New Diagnostics said it would cover the cost of developing
the test, conducting clinical trials and registering Proteome's rapid
diagnostic test that relies on antigens for determining the presence of
TB and measuring the severity of its infection within 3 minutes.

Related Summaries